These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31091208)
1. Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-Mesenchymal Transition. Liu C; Wang H; Li H; Chen X; Wu X; Lu B; Zhang W; Zhou Y; Xiao GG; Gao G Pancreas; 2019; 48(5):629-635. PubMed ID: 31091208 [TBL] [Abstract][Full Text] [Related]
2. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells. Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088 [TBL] [Abstract][Full Text] [Related]
3. [ Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584 [TBL] [Abstract][Full Text] [Related]
4. Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells. Chang ZG; Wei JM; Qin CF; Hao K; Tian XD; Xie K; Xie XH; Yang YM Dig Dis Sci; 2012 May; 57(5):1181-9. PubMed ID: 22271412 [TBL] [Abstract][Full Text] [Related]
5. [Effect of SIRT7 on inhibiting the epithelial-mesenchymal transformation in pancreatic cancer cells and related mechanism]. Wang MD; Gao TY; Huang W; Yang YK; Wang Y Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):566-582. PubMed ID: 38880736 [No Abstract] [Full Text] [Related]
6. Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Kyuno D; Kojima T; Yamaguchi H; Ito T; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N Carcinogenesis; 2013 Jun; 34(6):1232-43. PubMed ID: 23389293 [TBL] [Abstract][Full Text] [Related]
7. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer. Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285 [TBL] [Abstract][Full Text] [Related]
8. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells. Zhu H; Qin H; Li DM; Liu J; Zhao Q Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670 [TBL] [Abstract][Full Text] [Related]
9. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Sun XD; Liu XE; Huang DS Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1. Yang Y; Tao X; Li CB; Wang CM Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739 [TBL] [Abstract][Full Text] [Related]
11. [Regulatory mechanisms of Hedgehog signaling pathway for epithelial-mesenchymal transition in pancreatic cancer cells]. Xie K; Hao K; Tian XD; Chang ZG; Qin CF; Yang YM Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3103-6. PubMed ID: 22340649 [TBL] [Abstract][Full Text] [Related]
12. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer. Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 induces EMT and vimentin expression in PANC-1 pancreatic cancer cells: Involvement of BLT2 via ERK2 activation. Kim YR; Park MK; Kang GJ; Kim HJ; Kim EJ; Byun HJ; Lee MY; Lee CH Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():67-76. PubMed ID: 27914516 [TBL] [Abstract][Full Text] [Related]
14. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase. Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway. Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Lonp1 induces mitochondrial remodeling and autophagy suppression in cervical cancer cells. Wang X; Xu X; Zhao Y; Qi L; Ge H Acta Histochem; 2023 Jan; 125(1):151986. PubMed ID: 36508908 [TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865 [TBL] [Abstract][Full Text] [Related]
18. Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway. Zhang Y; Zhou M; Wei H; Zhou H; He J; Lu Y; Wang D; Chen B; Zeng J; Peng W; Du F; Gong A; Xu M Int J Oncol; 2017 Apr; 50(4):1352-1362. PubMed ID: 28259973 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060 [TBL] [Abstract][Full Text] [Related]
20. Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway. Jung DE; Kim JM; Kim C; Song SY Mol Carcinog; 2016 May; 55(5):633-45. PubMed ID: 25773908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]